175 related articles for article (PubMed ID: 26637668)
1. Recurrent MLK4 Loss-of-Function Mutations Suppress JNK Signaling to Promote Colon Tumorigenesis.
Marusiak AA; Stephenson NL; Baik H; Trotter EW; Li Y; Blyth K; Mason S; Chapman P; Puto LA; Read JA; Brassington C; Pollard HK; Phillips C; Green I; Overman R; Collier M; Testoni E; Miller CJ; Hunter T; Sansom OJ; Brognard J
Cancer Res; 2016 Feb; 76(3):724-35. PubMed ID: 26637668
[TBL] [Abstract][Full Text] [Related]
2. Mixed lineage kinase MLK4 is activated in colorectal cancers where it synergistically cooperates with activated RAS signaling in driving tumorigenesis.
Martini M; Russo M; Lamba S; Vitiello E; Crowley EH; Sassi F; Romanelli D; Frattini M; Marchetti A; Bardelli A
Cancer Res; 2013 Mar; 73(6):1912-21. PubMed ID: 23319808
[TBL] [Abstract][Full Text] [Related]
3. Decrease of MLK4 prevents hepatocellular carcinoma (HCC) through reducing metastasis and inducing apoptosis regulated by ROS/MAPKs signaling.
Li Y; Zuo H; Wang H; Hu A
Biomed Pharmacother; 2019 Aug; 116():108749. PubMed ID: 31071576
[TBL] [Abstract][Full Text] [Related]
4. Clinical Evidence on the Interaction Between MLK4, KRAS and Microsatellite Instability to Determine the Prognosis of Early-Stage Colorectal Carcinoma.
Brandl L; Horst D; Grünewald TGP; Mayerle J; Sendelhofert A; Neumann J; Kirchner T; De Toni EN
Cell Physiol Biochem; 2019; 53(5):820-831. PubMed ID: 31701729
[TBL] [Abstract][Full Text] [Related]
5. MLK4 has negative effect on TLR4 signaling.
Seit-Nebi A; Cheng W; Xu H; Han J
Cell Mol Immunol; 2012 Jan; 9(1):27-33. PubMed ID: 21602844
[TBL] [Abstract][Full Text] [Related]
6. Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway.
You S; Li W; Guan Y
Mol Med Rep; 2018 Mar; 17(3):4203-4212. PubMed ID: 29344654
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells.
Marusiak AA; Prelowska MK; Mehlich D; Lazniewski M; Kaminska K; Gorczynski A; Korwat A; Sokolowska O; Kedzierska H; Golab J; Biernat W; Plewczynski D; Brognard J; Nowis D
Oncogene; 2019 Apr; 38(15):2860-2875. PubMed ID: 30552384
[TBL] [Abstract][Full Text] [Related]
8. MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance.
Mehlich D; Łomiak M; Sobiborowicz A; Mazan A; Dymerska D; Szewczyk ŁM; Mehlich A; Borowiec A; Prełowska MK; Gorczyński A; Jabłoński P; Iżycka-Świeszewska E; Nowis D; Marusiak AA
Cell Death Dis; 2021 Nov; 12(12):1111. PubMed ID: 34839359
[TBL] [Abstract][Full Text] [Related]
9. Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.
Kim SH; Ezhilarasan R; Phillips E; Gallego-Perez D; Sparks A; Taylor D; Ladner K; Furuta T; Sabit H; Chhipa R; Cho JH; Mohyeldin A; Beck S; Kurozumi K; Kuroiwa T; Iwata R; Asai A; Kim J; Sulman EP; Cheng SY; Lee LJ; Nakada M; Guttridge D; DasGupta B; Goidts V; Bhat KP; Nakano I
Cancer Cell; 2016 Feb; 29(2):201-13. PubMed ID: 26859459
[TBL] [Abstract][Full Text] [Related]
10. Effects of bisphenol A on the proliferation, migration, and tumor growth of colon cancer cells: In vitro and in vivo evaluation with mechanistic insights related to ERK and 5-HT3.
Jun JH; Oh JE; Shim JK; Kwak YL; Cho JS
Food Chem Toxicol; 2021 Dec; 158():112662. PubMed ID: 34743013
[TBL] [Abstract][Full Text] [Related]
11. A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancers.
Šuštić T; van Wageningen S; Bosdriesz E; Reid RJD; Dittmar J; Lieftink C; Beijersbergen RL; Wessels LFA; Rothstein R; Bernards R
Genome Med; 2018 Nov; 10(1):90. PubMed ID: 30482246
[TBL] [Abstract][Full Text] [Related]
12. Anti-allergic drug azelastine suppresses colon tumorigenesis by directly targeting ARF1 to inhibit IQGAP1-ERK-Drp1-mediated mitochondrial fission.
Hu HF; Xu WW; Li YJ; He Y; Zhang WX; Liao L; Zhang QH; Han L; Yin XF; Zhao XX; Pan YL; Li B; He QY
Theranostics; 2021; 11(4):1828-1844. PubMed ID: 33408784
[TBL] [Abstract][Full Text] [Related]
13. Truncation- and motif-based pan-cancer analysis reveals tumor-suppressing kinases.
Hudson AM; Stephenson NL; Li C; Trotter E; Fletcher AJ; Katona G; Bieniasz-Krzywiec P; Howell M; Wirth C; Furney S; Miller CJ; Brognard J
Sci Signal; 2018 Apr; 11(526):. PubMed ID: 29666306
[TBL] [Abstract][Full Text] [Related]
14. microRNA-375 inhibits colorectal cancer cells proliferation by downregulating JAK2/STAT3 and MAP3K8/ERK signaling pathways.
Wei R; Yang Q; Han B; Li Y; Yao K; Yang X; Chen Z; Yang S; Zhou J; Li M; Yu H; Yu M; Cui Q
Oncotarget; 2017 Mar; 8(10):16633-16641. PubMed ID: 28186962
[TBL] [Abstract][Full Text] [Related]
15. Selective activation of tumor-suppressive MAPKP signaling pathway by triptonide effectively inhibits pancreatic cancer cell tumorigenicity and tumor growth.
Zhang B; Meng M; Xiang S; Cao Z; Xu X; Zhao Z; Zhang T; Chen B; Yang P; Li Y; Zhou Q
Biochem Pharmacol; 2019 Aug; 166():70-81. PubMed ID: 31075266
[TBL] [Abstract][Full Text] [Related]
16. PIK3CA mutation uncouples tumor growth and cyclin D1 regulation from MEK/ERK and mutant KRAS signaling.
Halilovic E; She QB; Ye Q; Pagliarini R; Sellers WR; Solit DB; Rosen N
Cancer Res; 2010 Sep; 70(17):6804-14. PubMed ID: 20699365
[TBL] [Abstract][Full Text] [Related]
17. RSK activation via ERK modulates human colon cancer cells response to PTHrP.
Calvo N; Carriere P; Martin MJ; Gentili C
J Mol Endocrinol; 2017 Jul; 59(1):13-27. PubMed ID: 28385776
[TBL] [Abstract][Full Text] [Related]
18. Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway.
Tseng YS; Lee JC; Huang CY; Liu HS
BMC Cancer; 2009 Dec; 9():435. PubMed ID: 20003375
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors.
Gupta J; Igea A; Papaioannou M; Lopez-Casas PP; Llonch E; Hidalgo M; Gorgoulis VG; Nebreda AR
Oncotarget; 2015 Apr; 6(11):8539-51. PubMed ID: 25890501
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between CCL7 and CCR3 promotes metastasis of colon cancer cells via ERK-JNK signaling pathways.
Lee YS; Kim SY; Song SJ; Hong HK; Lee Y; Oh BY; Lee WY; Cho YB
Oncotarget; 2016 Jun; 7(24):36842-36853. PubMed ID: 27167205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
